AAN REVIEW: Snapshots of new Parkinson's and Alzheimer's therapies
This article was originally published in Scrip
Executive Summary
Parkinson's and Alzheimer's disease presentations at the 65th American Academy of Neurology (AAN) Annual Meeting in San Diego from 16 to 23 March tended toward imaging and biomarker studies rather than clinical trial data for therapeutics, but some drug trial results were presented at the week-long conference.